breast cancer treatment

Aug 05, 2025

Anbogen’s ABT-301 Cleared by FDA for Phase I/II Colorectal Cancer Trial; Dyne’s DYNE-251 Gets FDA Breakthrough Tag for Duchenne Muscular Dystrophy; BMS’s BREYANZI Accepted for FDA Priority Review in MZL; Clarametyx’s CMTX-101 Earns FDA Fast Track and QIDP for Infections; Anixa Begins FDA-Approved IND Transfer for Phase II Breast Cancer Vaccine Trial

Aug 14, 2024

Breast Cancer Insights: Identifying Symptoms and Protecting Your Health

Aug 13, 2024

7 Most Common Myths About Breast Cancer Demystified

Mar 13, 2023

Cancer Biomarkers: Improving Treatment and Detection

Aug 04, 2017

CDK 4/6 Inhibitors- The Changing Paradigm for Breast Cancer Treatment

Newsletter/Whitepaper